Firma Clinical Research Earns ISO 9001 QMS Recertification

||Firma Clinical Research Earns ISO 9001 QMS Recertification

Firma Clinical Research Earns ISO 9001 QMS Recertification

Firma recently achieved ISO 9001 (International Organization for Standardization) processes recertification. ISO 9001 is the internationally recognized standard for QMS from the NQA, an independent, accredited certification body.

ISO 9001 provides a framework and set of principles that ensure a common-sense approach to the management of an organization to consistently satisfy customers and other stakeholders. In simple terms, it provides the basis for effective processes and effective people to deliver an effective product or service time after time.

“Firma’s implementation of the ISO standard helps guide measurable processes and consistent results, ensuring that our client deliverables are of the highest quality and value,” says Michael Woods, Chief Executive Officer, Firma Clinical Research. “We are committed to meeting or exceeding our drug-development customers’ requirements and expectations, and Firma adds to this value by putting patient centricity into all aspects of our customers’ clinical trials. The ISO 9001 recertification is external validation of Firma’s patient focus, transparency, measurable outcomes and continuous improvement.”

ISO 9001 is the most widely used QMS standard in the world, with certificates issued to organizations in 178 countries. NQA has provided assessments (audits) of organizations to various Management System Standards since 1988.

2019-11-13T19:47:56+00:00November 13th, 2019|Categories: News & Media|Tags: , , , |